Burney Company’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$349K Sell
6,318
-195,667
-97% -$10.8M 0.01% 472
2025
Q1
$9.77M Buy
+201,985
New +$9.77M 0.36% 75